Chronic nephritic syndrome with diffuse endocapillary proliferative glomerulonephritis
ICD-10 N03.4 is a billable code used to indicate a diagnosis of chronic nephritic syndrome with diffuse endocapillary proliferative glomerulonephritis.
Chronic nephritic syndrome with diffuse endocapillary proliferative glomerulonephritis is characterized by persistent inflammation of the glomeruli, leading to significant renal impairment. This condition is marked by the presence of hematuria, proteinuria, and hypertension. Patients often present with edema and may experience renal insufficiency over time. The diffuse endocapillary proliferation indicates an increase in the number of cells within the capillary loops of the glomeruli, which can be identified through renal biopsy. This condition can be secondary to various underlying diseases, including infections, autoimmune disorders, or systemic diseases. Management typically involves controlling blood pressure, reducing proteinuria, and addressing the underlying cause, which may include immunosuppressive therapy. Regular monitoring of renal function and urinalysis is essential to assess disease progression and treatment efficacy.
Detailed clinical notes on symptoms, lab results, and treatment plans.
Patients presenting with hematuria, proteinuria, and renal insufficiency.
Ensure accurate representation of biopsy findings and treatment response.
Comprehensive history and physical examination notes, including comorbidities.
Management of chronic kidney disease with nephritic syndrome.
Coordination with nephrology for complex cases.
When a renal biopsy is performed to confirm the diagnosis of chronic nephritic syndrome.
Document indication for biopsy, findings, and any complications.
Nephrology specialists should ensure proper coding based on biopsy results.
Key symptoms include hematuria, proteinuria, hypertension, and edema. Patients may also experience fatigue and renal insufficiency.
